Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OTLK
OTLK
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OTLK News
FDA Approves Eye Disease Drug Lytenava, Shares Surge
2d ago
stocktwits
Outlook Therapeutics Completes Stock Offering
2d ago
Yahoo Finance
Outlook Therapeutics Prices $5 Million Stock Offering
2d ago
NASDAQ.COM
SciSparc Receives Approval to Acquire Stake in Israeli Tech Firm
2d ago
NASDAQ.COM
Multiple Companies See Significant Stock Price Gains
4d ago
NASDAQ.COM
RDW Stock Rises 26% Amid Space Sector Euphoria Following SpaceX Debut
4d ago
stocktwits
Outlook Therapeutics Shares Surge 38% After FDA Appeal Win
4d ago
NASDAQ.COM
FDA Grants Approval for OTLK Eye Disease Treatment
5d ago
stocktwits
Outlook Therapeutics Secures FDA Approval for ONS-5010
5d ago
NASDAQ.COM
Outlook Therapeutics Reports Q2 Earnings Miss
May 15 2026
seekingalpha
Outlook Therapeutics Announces $5M Stock Offering of 16.12M Shares
Apr 22 2026
seekingalpha
Outlook Therapeutics Enters Stock Purchase Agreement
Apr 22 2026
Newsfilter
Outlook Therapeutics Completes Key Meeting with FDA on ONS-5010
Apr 21 2026
Newsfilter
Outlook Therapeutics' FDA Dispute Resolution Request Accepted
Apr 08 2026
NASDAQ.COM
Outlook Therapeutics Submits FDA Dispute Resolution Request for ONS-5010
Apr 07 2026
Newsfilter
Outlook Therapeutics Shares Drop 34% After Pricing Public Offering
Mar 24 2026
seekingalpha
Show More News
